Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 674 of 6351
-
New HIV strategy aims to curb epidemic among nigerian teens
Disease control Recruiting nowTwo combination interventions (HIV Case Finding Intervention and HIV Treatment Intervention), each with mHealth and Peer Navigation components, will be evaluated in two 48-week parallel hybrid effectiveness/implementation trials among youth aged 15-24 in Nigeria.
Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Spinal injury drug combo shows promise for restoring leg function
Disease control Recruiting nowThe purpose of this study is to test a strategy to potentiate functional recovery of lower limb motor function in individuals with spinal cord injury (SCI). The FDA approved drug, Dalfampridine (4-AP). 4-AP will be used twice-daily in combination of Spike-timing-dependent plastic…
Phase 1/2 • Sponsor: Shirley Ryan AbilityLab • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New hope for young brain cancer patients: targeted drug combo enters phase 2 trial
Disease control Recruiting nowThe goal of this study is to determine the efficacy of the study drug olutasidenib to treat newly diagnosed pediatric and young adult patients with a high-grade glioma (HGG) harboring an IDH1 mutation. The main question the study aims to answer is whether the combination of olut…
Phase 2 • Sponsor: Rigel Pharmaceuticals • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New daily pill could stop debilitating swelling attacks in HAE patients
Disease control Recruiting nowThis is a Phase 3, multicenter, long-term, open-label study to evaluate the safety and efficacy of once-daily orally administered deucrictibant extended-release tablet for prophylaxis to prevent angioedema attacks in participants aged ≥12 years with Hereditary Angioedema
Phase 3 • Sponsor: Pharvaris Netherlands B.V. • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
A new window into Babies' eyes: can advanced imaging improve care for premature infants?
Diagnosis Recruiting nowThe goal of this proposal is to develop novel HH-SECTR technology for visualizing and quantifying diagnostic disease features in prematurely born infant retinopathy of prematurity (ROP) patients that lead to more informed clinical decision making. Providing depth-resolved vascula…
Sponsor: Vanderbilt University Medical Center • Aim: Diagnosis
Last updated Aug 06, 2026 00:00 UTC
-
Real-world data on two-drug combo for hard-to-treat hodgkin lymphoma
Disease control CompletedApproximately 20% of patients diagnosed with Hodgkin lymphoma will eventually experience progression or relapse after first-line treatment, which carries a significant risk of disease-related death. Although several pilot studies have demonstrated high rates of sustained response…
Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Nipple-saving breast surgery under the microscope: is it safe for gene carriers?
Knowledge-focused Recruiting nowPatients with a germline pathogenic variant (GPV) in high-penetrance breast cancer susceptibility genes who are considering risk reducing mastectomy (RRM) often strongly desire to keep their nipple areola complex but inquire as to whether it is safe to do so. Relative to traditio…
Sponsor: Sir Mortimer B. Davis - Jewish General Hospital • Aim: Knowledge-focused
Last updated Aug 20, 2026 00:00 UTC
-
New hope for breast cancer spread to liver: targeted chemo trial opens
Disease control Recruiting nowStudy Objective: To Evaluate the Efficacy of Albumin-Bound Paclitaxel Combined with Nedaplatin via Hepatic Arterial Infusion as Later-Line Therapy for Breast Cancer Patients with Liver Metastases After Failure of Standard Treatment. Outcome Measures:Primary Outcome: Liver Progre…
Phase 2 • Sponsor: Zhejiang Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Can a smartphone app bridge the mental health care gap?
Symptom relief OngoingRandomized Control Trial of AmDTx (new name DawnDTx) on waitlist patients waiting for first psychiatric consultation to determine if a digital mental health app can reduce PHQ8 and GAD7 scores during the waitlist period.
Sponsor: Institute of Mental Health, Singapore • Aim: Symptom relief
Last updated Aug 23, 2026 00:00 UTC
-
Can a smart digital program restore sleep for cancer survivors?
Symptom relief Recruiting nowThe primary objective of this feasibility study is to assess the feasibility and acceptability, and potential clinical significance of an adaptive stepped-care intervention for improving sleep quality among Chinese cancer patients with mild-to-moderate sleep disturbance, using a …
Sponsor: The University of Hong Kong • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Which laser best tames glaucoma pressure?
Disease control CompletedThis randomized, single-centre, three-arm trial compared three subvisible laser trabeculoplasty delivery protocols in eyes with open-angle glaucoma already receiving intraocular pressure (IOP)-lowering medication: selective laser trabeculoplasty (SLT, 3-nanosecond pulses), microp…
Sponsor: University of Udine • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New drug combo aims to tame hepatitis b virus
Disease control Recruiting nowBackground: Chronic hepatitis B virus (HBV) infection affects 292 million people worldwide; 887,000 die each year from cirrhosis, liver cancer, and related issues. Treatment options are limited. Objective: To test 2 drugs (VIR-2218 and peginterferon) in people with mild or ina…
Phase 2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
New pill could ease painful skin condition
Disease control OngoingThe purpose of this study is to establish the efficacy, safety, and tolerability of remibrutinib (LOU064) Dose A and Dose B compared to placebo in participants with moderate to severe hidradenitis suppurativa (HS).
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New dengue vaccine shows promise in japan trial
Vaccine CompletedDengue fever is caused by an infection with the dengue virus. Vaccination with TDV can help prevent dengue fever. The main purpose of this study is to learn about TDV's ability to create an immune response in adults, adolescents, and children administered. In this study, partici…
Phase 2/3 • Sponsor: Takeda • Aim: Vaccine
Last updated Jun 27, 2026 08:07 UTC
-
Massive stroke trial aims to Fine-Tune clot removal for better recovery
Disease control Recruiting nowSTEP is a Randomized, Multifactorial, Adaptive Platform trial that seeks to optimize the care of patients with acute ischemic stroke (AIS) due to large (LVO) or medium vessel occlusions (MVO).
Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Brain zaps timed to your own waves may boost memory in Alzheimer's
Disease control Recruiting nowThe project is a placebo-controlled study that aims to use closed-loop transcranial alternating current stimulation (tACS) to study patients with symptoms of mild cognitive impairment which is likely due to Alzheimer's disease or another form of dementia (AD-MCI). Patients will u…
Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Can mindfulness ease the emotional toll of IVF?
Symptom relief Recruiting nowThis randomized controlled trial aimed to determine whether a mindfulness-based lifestyle support program would improve quality of life, lifestyle, mindfulness, attention and meditation level and treatment outcomes in women undergoing IVF treatment.
Sponsor: Dokuz Eylul University • Aim: Symptom relief
Last updated Aug 27, 2026 00:00 UTC
-
Magic mushroom therapy for veterans: a new hope for PTSD?
Symptom relief Recruiting nowThe principal investigator for this study plans to build upon the psilocybin-assisted therapy intervention used in prior completed trials to conduct an open-label trial of two psilocybin administration sessions combined with psychotherapy to investigate the safety, tolerability, …
Phase 2 • Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
New hope for brain cancer? drug trial targets recurrent glioblastoma
Disease control Recruiting nowThe goal of Phase 1 of this clinical research study is to find the highest tolerable dose and the recommended Phase 2 dose of ivonescimab that can be given to patients who have recurrent glioblastoma. The goal of Phase 2 of this clinical research study is to learn if the recomme…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New combo therapy aims to beat tough blood cancer
Disease control Recruiting nowThe goal of this phase 2 clinical trial is to test the efficacy of decitabine and venetoclax combination chemotherapy in relapsed or refractory adult T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma. This study use a modified regimen of decitabine and venetoclax.
Phase 2 • Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC